Sean F. Scanlan - Chief Innovation Officer at TREACE MEDICAL CONCEPTS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Innovation Officer
Issuer Symbol
TMCI on Nasdaq
All Insider Reports
All Insider Reports

Sean F. Scanlan - trading volume in the past year for TREACE MEDICAL CONCEPTS, INC.

Holdings reported by Sean F. Scanlan for TREACE MEDICAL CONCEPTS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 706,474 $741,797 $1.05 10 Feb 2026 Direct
Stock Option (Right to Buy) 0 10 Feb 2026 Direct Common Stock

Transactions reported by Sean F. Scanlan for TREACE MEDICAL CONCEPTS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.